These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 2880362

  • 21. Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms.
    Gil-ad I, Shtaif B, Shiloh R, Weizman A.
    Cell Mol Neurobiol; 2001 Dec; 21(6):705-16. PubMed ID: 12043843
    [Abstract] [Full Text] [Related]

  • 22. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB, Caligiuri MP.
    J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
    [Abstract] [Full Text] [Related]

  • 23. Neurologic approach to drug-induced movement disorders: a study of 125 patients.
    Miller LG, Jankovic J.
    South Med J; 1990 May; 83(5):525-32. PubMed ID: 1971459
    [Abstract] [Full Text] [Related]

  • 24. Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia. A double-blind cross-over study with placebo.
    Friis T, Christensen TR, Gerlach J.
    Acta Psychiatr Scand; 1983 Mar; 67(3):178-87. PubMed ID: 6134430
    [No Abstract] [Full Text] [Related]

  • 25. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
    Meszaros K, Lenzinger E, Hornik K, Schönbeck G, Hatzinger R, Langer G, Sieghart W, Aschauer HN.
    Neuropsychobiology; 1997 Mar; 36(2):69-72. PubMed ID: 9267855
    [Abstract] [Full Text] [Related]

  • 26. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD, Beasley CM, Tamura RN, Tran PV, Potvin JH.
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [Abstract] [Full Text] [Related]

  • 27. Effect of anticholinergics on tardive dyskinesia. A controlled discontinuation study.
    Greil W, Haag H, Rossnagl G, Rüther E.
    Br J Psychiatry; 1984 Sep; 145():304-10. PubMed ID: 6148119
    [Abstract] [Full Text] [Related]

  • 28. Early extrapyramidal side-effects as risk factors for later tardive dyskinesia: a prospective study.
    Sachdev P.
    Aust N Z J Psychiatry; 2004 Jun; 38(6):445-9. PubMed ID: 15209837
    [Abstract] [Full Text] [Related]

  • 29. The natural history of tardive dyskinesia.
    Gardos G, Cole JO, Haskell D, Marby D, Paine SS, Moore P.
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068
    [Abstract] [Full Text] [Related]

  • 30. Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
    Domino EF.
    Psychopharmacology Suppl; 1985 Aug; 2():217-23. PubMed ID: 2860660
    [Abstract] [Full Text] [Related]

  • 31. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
    Richardson MA, Haugland G, Craig TJ.
    Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296
    [Abstract] [Full Text] [Related]

  • 32. Tardive dyskinesia in the aged. Duration of treatment relationships.
    Toenniessen LM, Casey DE, McFarland BH.
    Arch Gen Psychiatry; 1985 Mar; 42(3):278-84. PubMed ID: 2858189
    [Abstract] [Full Text] [Related]

  • 33. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV, Montejo González AL, Martín Carrasco M.
    Actas Esp Psiquiatr; 2003 Mar; 31(6):347-52. PubMed ID: 14639511
    [Abstract] [Full Text] [Related]

  • 34. Differential antagonism of antiavoidance, cataleptic and ptotic effects of neuroleptics by biperiden.
    Oka M, Yamada K, Kamei C, Yoshida K, Shimizu M.
    Jpn J Pharmacol; 1979 Jun; 29(3):435-45. PubMed ID: 43913
    [Abstract] [Full Text] [Related]

  • 35. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients.
    Jeste DV, Lacro JP, Bailey A, Rockwell E, Harris MJ, Caligiuri MP.
    J Am Geriatr Soc; 1999 Jun; 47(6):716-9. PubMed ID: 10366172
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Buspirone in the treatment of tardive dyskinesia.
    Moss LE, Neppe VM, Drevets WC.
    J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
    [Abstract] [Full Text] [Related]

  • 38. Preventing neuroleptic-induced tardive dyskinesia in adults and children.
    Lam RW, Jeste SD, Jeste DV.
    Encephale; 1988 Sep; 14 Spec No():251-5. PubMed ID: 2905652
    [Abstract] [Full Text] [Related]

  • 39. Underrecognition of tardive dyskinesia and drug-induced parkinsonism by psychiatric residents.
    Hansen TE, Brown WL, Weigel RM, Casey DE.
    Gen Hosp Psychiatry; 1992 Sep; 14(5):340-4. PubMed ID: 1355749
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.